Effect of Duolac 7S Administration on Improving Symptom in Irritable Bowel Syndrome

Clinical trial NCT01088971 · COMPLETED

Trial details

NCT number: NCT01088971
Sponsor: Cell Biotech Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Irritable Bowel Syndrome

Start date: 2009-10-01
Primary completion: 2011-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.